Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

HealthRX vs Bionomy Health

Two GLP-1 desks, one scoreboard. We put HealthRX and Bionomy Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 7 · Grade B

HealthRX

Visit HealthRX Full brief →
vs
No. 35 · Grade B

Bionomy Health

Visit Bionomy Health Full brief →

The verdict

HealthRX takes this head-to-head.

HealthRX scores 86 to 83 on our six-factor Brief Score — A LegitScript-certified, physician-supervised desk (healthrx.com) whose real hook is breadth: injectable and a rare oral GLP tablet, on both molecules, with transparent no-insurance monthly pricing.

That doesn't make Bionomy Health a bad call — it's best for readers who want men seeking physician-led compounded glp-1 weight loss with trt and longevity add-ons. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
85
78
Supply Reliability
85
81
Transparency
83
94
Access Breadth
91
90
Clinical Oversight
89
78
Track Record
81
74
HealthRXBrief Score 86 · 83Bionomy Health

Price, coverage & the tracker

HealthRXBionomy Health
Brief Score86/100 (B)83/100 (B)
Semaglutide$189/mo$189/mo
Tirzepatide$349/mo$249/mo
CoverageNot publicly listed48 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

HealthRX: Company-stated tiers held flat this cycle; the LegitScript badge and a rare oral GLP tablet are the draw, but some tiers are self-reported rather than checkout-verified.

Bionomy Health: New to the tracker on 1 August 2026. The published line reads $189/mo at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.